镰状细胞病治疗市场- 按治疗方式[输血、药物治疗（羟基脲、Oxybryta、Endari）、骨髓移植]、按疾病（镰状细胞贫血、血红蛋白Sickle C）、按最终用户和预测，2023-2032年

2023-2032年全球镰状细胞病治疗市场将保持稳定增长。镰状细胞病的高患病率，特别是在撒哈拉以南非洲和中东的一些地区，需要有效的治疗方案。据 CDC 称，SCD 影响了大约 100,000 名美国人。此外，大约每 365 名黑人或非裔美国人新生儿中就有 1 人患有这种疾病。

医学研究和技术的进步促进了新疗法的发展，包括基因疗法和靶向药物，改善了患者的治疗效果。此外，政府的倡议以及与製药公司的合作也促进了更多的治疗选择。此外，医疗保健专业人员和患者对疾病早期诊断和管理重要性的认识不断提高，进一步刺激了镰状细胞病治疗市场对创新治疗的需求。

总体市场份额根据治疗方式、疾病、最终用户和地区进行分类。

根据治疗方式，骨髓移植领域将从2023 年到2032 年对市场收入做出重大贡献。这种治疗方案通过用来自相容捐赠者的健康干细胞替换有缺陷的干细胞，为镰状细胞病提供了潜在的治愈方法。随着人们对这种治疗方法的认识不断增强，越来越多的患者和医疗保健专业人员正在考虑将骨髓移植作为一种可行的解决方案。移植技术的进步和对匹配标准的更好理解提高了成功率，使骨髓移植成为越来越受欢迎的选择。

按疾病划分，血红蛋白镰状细胞病(HbSC) 细分市场将在2023 年至2032 年期间呈现高增长率，并可能在2032 年主导镰状细胞病治疗市场份额。HbSC 是镰状细胞病的一种较温和的形式，但仍可能导致并发症并影响受影响个体的生活质量。随着人们对HbSC 的认识和了解不断增加，对靶向治疗和支持性护理方案的需求不断增长，以管理症状并改善患者的整体健康状况，从长远来看，这将有利于细分市场的增长。

至于最终用户，到 2032 年，镰状细胞治疗行业的专科诊所部分将录得不错的估值。这些诊所提供管理镰状细胞病的专门护理和专业知识，为患者提供全面的治疗方案和支持。专科诊所专注于个性化护理和量身定制的治疗计划，在改善患者治疗效果和生活质量方面发挥着至关重要的作用。人们对镰状细胞病专门护理重要性的认识不断提高，导致镰状细胞病治疗市场对这些诊所的需求不断增长。

从区域来看，由于该地区对镰状细胞病的认识不断提高和诊断的改进，欧洲镰状细胞病治疗市场将在预测期内获得牵引力。该地区强大的医疗基础设施以及先进的医学研究和技术支持创新疗法的开发和可用性。此外，政府的倡议以及与製药公司的合作促进了该领域的研究和开发。对改善患者治疗结果和提高生活质量的日益关注推动了欧洲对镰状细胞病治疗的需求。

目录

第 1 章：方法和范围

第 2 章：执行摘要

第 3 章：镰状细胞病治疗市场洞察

• 行业格局，2018 - 2032
• 行业影响力
  • 增长动力
    • 镰状细胞病患病率增加
    • 增加镰状细胞病药物开发的研发活动
    • 增加医疗支出和政府倡议
  • 行业陷阱与挑战
    • 与治疗相关的高费用
    • 与镰状细胞病治疗药物相关的副作用
• 增长潜力分析
  • 按治疗方式
  • 按疾病类型
  • 按最终用户
• COVID-19 影响分析
• 临床试验分析
• 监管环境
• 波特的分析
• PESTEL分析

第 4 章：竞争格局，2022 年

• 介绍
• 2022 年公司矩阵分析
• 2022 年全球公司市场份额分析
• 2022 年竞争定位矩阵
• 战略仪表板，2022 年

第 5 章：镰状细胞病治疗市场估计和预测：按治疗方式

• 按治疗方式分類的主要趋势
• 输血
• 药物治疗
  • 按药物类型
    • 羟基脲
    • 奥克西布里塔
    • 阿达克维奥
    • 恩达里
    • 其他药物疗法
  • 按给药途径
    • 口服
    • 注射用
• 骨髓移植

第 6 章：镰状细胞病治疗市场估计和预测：按疾病类型

• 按疾病类型分類的主要趋势
• 镰状细胞性贫血
• 血红蛋白镰状 C 病 (HbSC)
• 其他疾病类型

第 7 章：镰状细胞病治疗市场估计和预测：按最终用户

• 主要趋势（按最终用户）
• 医院
• 专科诊所
• 其他最终用户

第 8 章：镰状细胞病治疗市场估计和预测：按地区

• 按地区分類的主要趋势
• 北美
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 意大利
  • 瑞士
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳大利亚
  • 韩国
  • 亚太地区其他地区
• 拉美
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 南非
  • 沙特阿拉伯
  • MEA 的其余部分

第 9 章：公司简介

• Pfizer, Inc.
• Novartis AG
• Emmaus Medical, Inc.
• Medunik USA, Inc.
• Bristol-Myers Squibb Company
• Bluebird Bio, Inc.
• Agios Pharmaceuticals
• CRISPR Therapeutics
• Vifor Pharma
• Editas Medicine Inc.

Global Sickle Cell Disease Treatment Market will have a stable growth rate from 2023-2032. The high prevalence of sickle cell disease, particularly in sub-Saharan Africa and some parts of the Middle East, demands effective treatment options. According to CDC, SCD affects an estimated 100,000 Americans. Also, the disease occurs in about 1 in every 365 Black or African American births.

Advancements in medical research and technology have led to the development of novel therapies, including gene therapies and targeted drugs, improving patient outcomes. In addition, government initiatives and collaborations with pharmaceutical companies have facilitated increased access to treatment options. Moreover, growing awareness among healthcare professionals and patients about the importance of early diagnosis and management of the disease has further fuelled the demand for innovative treatments in the Sickle Cell Disease Treatment Market.

The overall market share is classified based on treatment modality, disease, end-user, and region.

Based on treatment modality, the bone marrow transplant segment will contribute significantly to the market revenue from 2023 to 2032. This treatment option offers a potential cure for sickle cell disease by replacing defective stem cells with healthy ones from a compatible donor. As awareness of this therapeutic approach grows, more patients and healthcare professionals are considering bone marrow transplants as a viable solution. Advances in transplant techniques and a better understanding of matching criteria have improved success rates, making bone marrow transplants an increasingly sought-after option.

By disease, the hemoglobin sickle C disease (HbSC) segment will show a high growth rate from 2023-2032 and could dominate the sickle cell disease treatment market share by 2032. HbSC is a milder form of sickle cell disease, but it can still cause complications and affect the quality of life for affected individuals. As awareness and understanding of HbSC increase, there is a growing need for targeted therapies and supportive care options to manage symptoms and improve patients' overall well-being, which will favor segment growth in the long run.

Regarding end-user, the specialty clinics segment of the sickle cell treatment industry will record a decent valuation by 2032. These clinics offer specialized care and expertise in managing sickle cell disease, providing comprehensive treatment options and support to patients. With a focus on personalized care and tailored treatment plans, specialty clinics play a crucial role in improving patient outcomes and quality of life. The rising awareness of the importance of specialized care for sickle cell disease has led to a growing demand for these clinics in the Sickle Cell Disease Treatment Market.

Regionally, the Europe sickle cell disease treatment market will gain traction during the forecast period due to increasing awareness and improved diagnosis of sickle cell disease in the region. The region's strong healthcare infrastructure and access to advanced medical research and technologies support the development and availability of innovative therapies. Additionally, government initiatives and collaborations with pharmaceutical companies promote research and development in the field. The growing focus on improving patient outcomes and enhancing quality of life drives the demand for sickle cell disease treatment in Europe.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market definitions
• 1.2 Base estimates and calculations
• 1.3 Forecast calculations
• 1.4 Data sources
  • 1.4.1 Secondary
    • 1.4.1.1 Paid sources
    • 1.4.1.2 Public sources
  • 1.4.2 Primary

Chapter 2 Executive Summary

• 2.1 Sickle cell disease treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
  • 2.1.1 Business trends
  • 2.1.2 Region trends
  • 2.1.3 Treatment modality trends
  • 2.1.4 Disease type trends
  • 2.1.5 End-user trends

Chapter 3 Sickle Cell disease Treatment Market Insights

• 3.1 Industry landscape, 2018 - 2032 (USD Million)
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of sickle cell disease
    • 3.2.1.2 Increasing R&D activities in drug development for sickle cell disease
    • 3.2.1.3 Increasing healthcare expenditure and government initiatives
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High cost associated with the treatment
    • 3.2.2.2 Side effects associated with sickle cell disease treatment drugs
• 3.3 Growth potential analysis
  • 3.3.1 By treatment modality
  • 3.3.2 By disease type
  • 3.3.3 By end-user
• 3.4 COVID-19 impact analysis
• 3.5 Clinical trial analysis
• 3.6 Regulatory landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

• 4.1 Introduction
• 4.2 Company matrix analysis, 2022
• 4.3 Global company market share analysis, 2022
• 4.4 Competitive positioning matrix, 2022
• 4.5 Strategic dashboard, 2022

Chapter 5 Sickle Cell Disease Treatment Market Estimates and Forecast, By Treatment Modality (USD Million)

• 5.1 Key trends, by treatment modality
• 5.2 Blood transfusion
• 5.3 Pharmacotherapy
  • 5.3.1 By drug type
    • 5.3.1.1 Hydroxyurea
    • 5.3.1.2 Oxybryta
    • 5.3.1.3 Adakveo
    • 5.3.1.4 Endari
    • 5.3.1.5 Other pharmacotherapies
  • 5.3.2 By route of administration
    • 5.3.2.1 Oral
    • 5.3.2.2 Parenteral
• 5.4 Bone marrow transplant

Chapter 6 Sickle Cell Disease Treatment Market Estimates and Forecast, By Disease Type (USD Million)

• 6.1 Key trends, by disease type
• 6.2 Sickle cell anemia
• 6.3 Hemoglobin sickle C disease (HbSC)
• 6.4 Other disease types

Chapter 7 Sickle Cell Disease Treatment Market Estimates and Forecast, By End-user (USD Million)

• 7.1 Key trends, by end-user
• 7.2 Hospitals
• 7.3 Specialty clinics
• 7.4 Other end-users

Chapter 8 Sickle Cell Disease Treatment Market Estimates and Forecast, By Region (USD Million)

• 8.1 Key trends, by region
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 UK
  • 8.3.3 France
  • 8.3.4 Spain
  • 8.3.5 Italy
  • 8.3.6 Switzerland
  • 8.3.7 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Australia
  • 8.4.5 South Korea
  • 8.4.6 Rest of Asia Pacific
• 8.5 Latin America
  • 8.5.1 Brazil
  • 8.5.2 Mexico
  • 8.5.3 Rest of Latin America
• 8.6 Middle East & Africa
  • 8.6.1 South Africa
  • 8.6.2 Saudi Arabia
  • 8.6.3 Rest of MEA

Chapter 9 Company Profiles

• 9.1 Pfizer, Inc.
• 9.2 Novartis AG
• 9.3 Emmaus Medical, Inc.
• 9.4 Medunik USA, Inc.
• 9.5 Bristol-Myers Squibb Company
• 9.6 Bluebird Bio, Inc.
• 9.7 Agios Pharmaceuticals
• 9.8 CRISPR Therapeutics
• 9.9 Vifor Pharma
• 9.10 Editas Medicine Inc.

Data Tables

• TABLE 1 Product mapping
• TABLE 2 Market revenue, by treatment modality (2022)
• TABLE 3 Market revenue, by disease type (2022)
• TABLE 4 Market revenue, by end-user (2022)
• TABLE 5 Market share, by region (2022)
• TABLE 6 Global sickle cell disease treatment market size, by region, 2018 - 2022 (USD Million)
• TABLE 7 Global sickle cell disease treatment market size, by region, 2023 - 2032 (USD Million)
• TABLE 8 Global sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 9 Global sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 10 Global sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 11 Global sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 12 Global sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 13 Global sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 14 Industry impact forces
• TABLE 15 Competitive benchmarking of major market players
• TABLE 16 Competitive positioning matrix: Classification criteria
• TABLE 17 Strategic outlook matrix: Classification criteria
• TABLE 18 Blood transfusion market size, 2018 - 2022 (USD Million)
• TABLE 19 Blood transfusion market size, 2023 - 2032 (USD Million)
• TABLE 20 Pharmacotherapy market size, 2018 - 2022 (USD Million)
• TABLE 21 Pharmacotherapy market size, 2023 - 2032 (USD Million)
• TABLE 22 Pharmacotherapy market size, by drug type, 2018 - 2022 (USD Million)
• TABLE 23 Pharmacotherapy market size by drug type, 2023 - 2032 (USD Million)
• TABLE 24 Hydroxyurea market size, 2018 - 2022 (USD Million)
• TABLE 25 Hydroxyurea market size, 2023 - 2032 (USD Million)
• TABLE 26 Oxybryta market size, 2018 - 2022 (USD Million)
• TABLE 27 Oxybryta market size, 2023 - 2032 (USD Million)
• TABLE 28 Adakveo market size, 2018 - 2022 (USD Million)
• TABLE 29 Adakveo market size, 2023 - 2032 (USD Million)
• TABLE 30 Endari market size, 2018 - 2022 (USD Million)
• TABLE 31 Endari market size, 2023 - 2032 (USD Million)
• TABLE 32 Other pharmacotherapies market size, 2018 - 2022 (USD Million)
• TABLE 33 Other pharmacotherapies market size, 2023 - 2032 (USD Million)
• TABLE 34 Pharmacotherapy market size, by route of administration, 2018 - 2022 (USD Million)
• TABLE 35 Pharmacotherapy market size, by route of administration, 2023 - 2032 (USD Million)
• TABLE 36 Oral market size, 2018 - 2022 (USD Million)
• TABLE 37 Oral market size, 2023 - 2032 (USD Million)
• TABLE 38 Parenteral market size, 2018 - 2022 (USD Million)
• TABLE 39 Parenteral market size, 2023 - 2032 (USD Million)
• TABLE 40 Bone marrow transplant market size, 2018 - 2022 (USD Million)
• TABLE 41 Bone marrow transplant market size, 2023 - 2032 (USD Million)
• TABLE 42 Sickle cell anemia market size, 2018 - 2022 (USD Million)
• TABLE 43 Sickle cell anemia market size, 2023 - 2032 (USD Million)
• TABLE 44 Hemoglobin sickle C disease (HbSC) market size, 2018 - 2022 (USD Million)
• TABLE 45 Hemoglobin sickle C disease (HbSC) market size, 2023 - 2032 (USD Million)
• TABLE 46 Other disease types market size, 2018 - 2022 (USD Million)
• TABLE 47 Other disease types market size, 2023 - 2032 (USD Million)
• TABLE 48 Hospitals market size, 2018 - 2022 (USD Million)
• TABLE 49 Hospitals market size, 2023 - 2032 (USD Million)
• TABLE 50 Specialty clinics market size, 2018 - 2022 (USD Million)
• TABLE 51 Specialty clinics market size, 2023 - 2032 (USD Million)
• TABLE 52 Other end-users market size, 2018 - 2022 (USD Million)
• TABLE 53 Other end-users market size, 2023 - 2032 (USD Million)
• TABLE 54 North America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 55 North America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 56 North America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 57 North America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 58 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 59 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 60 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 61 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 62 North America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 63 North America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 64 North America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 65 North America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 66 U.S. sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 67 U.S. sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 68 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 69 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 70 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 71 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 72 U.S. sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 73 U.S. sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 74 U.S. sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 75 U.S. sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 76 Canada sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 77 Canada sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 78 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 79 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 80 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 81 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 82 Canada sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 83 Canada sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 84 Canada sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 85 Canada sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 86 Europe sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 87 Europe sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 88 Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 89 Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 90 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 91 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 92 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 93 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 94 Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 95 Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 96 Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 97 Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 98 Germany sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 99 Germany sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 100 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 101 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 102 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 103 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 104 Germany sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 105 Germany sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 106 Germany sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 107 Germany sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 108 UK sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 109 UK sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 110 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 111 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 112 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 113 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 114 UK sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 115 UK sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 116 UK sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 117 UK sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 118 France sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 119 France sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 120 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 121 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 122 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 123 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 124 France sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 125 France sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 126 France sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 127 France sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 128 Spain sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 129 Spain sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 130 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 131 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 132 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 133 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 134 Spain sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 135 Spain sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 136 Spain sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 137 Spain sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 138 Italy sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 139 Italy sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 140 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 141 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 142 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 143 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 144 Italy sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 145 Italy sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 146 Italy sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 147 Italy sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 148 Switzerland sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 149 Switzerland sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 150 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 151 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 152 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 153 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 154 Switzerland sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 155 Switzerland sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 156 Switzerland sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 157 Switzerland sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 158 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 159 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 160 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 161 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 162 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 163 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 164 Rest of Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 165 Rest of Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 166 Rest of Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 167 Rest of Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 168 Asia Pacific sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 169 Asia Pacific sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 170 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 171 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 172 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 173 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 174 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 175 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 176 Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 177 Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 178 Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 179 Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 180 China sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 181 China sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 182 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 183 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 184 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 185 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 186 China sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 187 China sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 188 China sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 189 China sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 190 Japan sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 191 Japan sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 192 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 193 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 194 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 195 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 196 Japan sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 197 Japan sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 198 Japan sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 199 Japan sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 200 India sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 201 India sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 202 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 203 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 204 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 205 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 206 India sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 207 India sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 208 India sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 209 India sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 210 Australia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 211 Australia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 212 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 213 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 214 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 215 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 216 Australia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 217 Australia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 218 Australia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 219 Australia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 220 South Korea sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 221 South Korea sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 222 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 223 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 224 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 225 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 226 South Korea sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 227 South Korea sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 228 South Korea sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 229 South Korea sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 230 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 231 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 232 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 233 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 234 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 235 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 236 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 237 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 238 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 239 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 240 Latin America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 241 Latin America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 242 Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 243 Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 244 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 245 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 246 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 247 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 248 Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 249 Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 250 Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 251 Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 252 Brazil sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 253 Brazil sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 254 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 255 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 256 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 257 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 258 Brazil sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 259 Brazil sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 260 Brazil sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 261 Brazil sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 262 Mexico sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 263 Mexico sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 264 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 265 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 266 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 267 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 268 Mexico sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 269 Mexico sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 270 Mexico sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 271 Mexico sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 272 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 273 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 274 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 275 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 276 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 277 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 278 Rest of Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 279 Rest of Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 280 Rest of Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 281 Rest of Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 282 MEA sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
• TABLE 283 MEA sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
• TABLE 284 MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 285 MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 286 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 287 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 288 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 289 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 290 MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 291 MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 292 MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 293 MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 294 South Africa sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 295 South Africa sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 296 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 297 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 298 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 299 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 300 South Africa sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 301 South Africa sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 302 South Africa sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 303 South Africa sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 304 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 305 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 306 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 307 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 308 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 309 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 310 Saudi Arabia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 311 Saudi Arabia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 312 Saudi Arabia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 313 Saudi Arabia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
• TABLE 314 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
• TABLE 315 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
• TABLE 316 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
• TABLE 317 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
• TABLE 318 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
• TABLE 319 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
• TABLE 320 Rest of MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
• TABLE 321 Rest of MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
• TABLE 322 Rest of MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
• TABLE 323 Rest of MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

• FIG 1 GMI report coverage: Critical research elements
• FIG 2 Top-down approach
• FIG 3 Market estimation and forecast methodology
• FIG 4 Market forecasting methodology
• FIG 5 Breakdown of primary participants
• FIG 6 Sickle cell disease treatment industry 360 degree synopsis, 2018 - 2032
• FIG 7 Growth potential analysis, by treatment modality
• FIG 8 Growth potential analysis, by disease type
• FIG 9 Growth potential analysis, by end-user
• FIG 10 Porter's analysis
• FIG 11 PESTEL analysis
• FIG 12 Company matrix analysis, 2022
• FIG 13 Global Company market share analysis, 2022
• FIG 14 Competitive positioning matrix, 2022
• FIG 15 Strategic dashboard, 2022